CytoAgents, Inc., a biotechnology company, manufactures protein based drugs for the treatment of influenza and other viral infectious diseases. The company offers GP1681, an agonist of a G-protein coupled receptor. CytoAgents, Inc. was incorporated in 2018 and is based in Pittsburgh, Pennsylvania.
C360 Technologies, Inc. specializes in the manufacturing of non-stitched immersive video products tailored for broadcast and over-the-top (OTT) platforms. Established in 2008 and based in Wexford, Pennsylvania, the company has developed innovative technology that allows for high-quality 6K immersive video without the need for multi-headed cameras or stitching. C360's offerings include compact, pro-grade immersive cameras and workstations that provide multiple live HD-SDI outputs directly to broadcasters, facilitating real-time production for live television events. Additionally, the technology enables simultaneous 4K streaming to OTT platforms, allowing for versatile distribution across various applications. Users can independently control camera settings during live events, enhancing the viewing experience. C360 Technologies has positioned itself as a pioneer in the immersive video industry, focusing on delivering unique solutions that meet the demands of modern broadcasting.
Augment Therapy, Inc. develops interactive augmented reality telemedicine software solution for pediatric physical therapy. The solution provides real-time and remote monitored session on physical therapy and automates data collection for therapists. Augment Therapy, Inc. was founded in 2017 and is based in Cleveland, Ohio.
OndeCare is an innovative marketplace that connects clients with professional caregivers for in-home care services. Designed for convenience, the platform allows users to book care quickly and efficiently, offering reliable, high-quality support for individuals of all ages and needs. OndeCare focuses on providing concierge-level assistance, ensuring that clients receive tailored services that fit their schedules and requirements. By facilitating these connections, the company not only addresses the caring needs of families but also generates meaningful job opportunities for local care, safety, and education professionals. The platform aims to make in-home care accessible and affordable, aligning its services with the costs of traditional home care solutions.
Gridwise, Inc. develops and operates a peer-to-peer driver intelligence mobile application for rideshare drivers. The company's software solution enables drivers to receive events and end time updates, real-time alerts, airport demand data, and maintain driver taskbar. Its application also enables to get alerts about traffic, weather, events letting out, and other nearby opportunities; calculate tax deductions and prepare detailed tax reports; automatically track mileage; and get real-time passenger data. Gridwise, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.
Edge Case Research, Inc. specializes in developing software products and safety systems for companies involved in self-driving vehicles and robotics. The company provides innovative tools such as Hologram, which helps users identify and resolve edge cases that challenge machine learning, and Switchboard, a cloud-based solution for automated robustness testing that assesses the safety and reliability of complex software. Edge Case Research employs Model-based Iterative System Safety Analysis to effectively identify and manage safety risks in intricate systems. Additionally, the company offers best practices assessments for embedded software and training in safety and peer review for software testing. Serving industries such as autonomous vehicles, consumer electronics, and industrial controls, Edge Case Research aims to enhance the safety and reliability of evolving technologies. Founded in 2013, the company is headquartered in Pittsburgh, Pennsylvania, with a branch in Unterschleißheim, Germany.
Aeronics is a technology company that is changing the way they store oxygen, so they can all breathe a little easier. We have 2 product offerings right now: Everyday Oxygen and Pawprint Oxygen. Our FDA approved device is launching in 2020.
BoardBookit, Inc. develops a board portal software for companies and boards of directors to simplify and enhance their board meetings and communications. It offers BoardBookit, a board room empowerment platform that provides secure tools to enhance information sharing, communication, and decision making between companies and their boards of directors. The company serves customers in the United States, Canada, Europe, and Australia. BoardBookit, Inc. was founded in 2012 and is based in Pittsburgh, Pennsylvania.
Cocomama is a women-owned business that manufactures delicious baking and hot cocoa mixes. It crafts organic cocoa products, cocoa powders, baking mixes, and brownie thins are used to produce cakes, pastries, and cookies with ingredients sourced from countries like the Dominican Republic, Madagascar, and Indonesia, providing customers with tasty chocolate products.
PittMoss LLC manufactures an innovative growing media called PittMoss, which consists of organic additives and recycled paper, catering to commercial greenhouses, nurseries, and home gardeners across the United States. The company also produces PittMoss Prime, a versatile soil amendment that can be combined with compost, existing soil blends, or native soil. Founded in 1994 and based in Ambridge, Pennsylvania, PittMoss focuses on sustainability and environmental responsibility, aiming to enhance soil health and improve gardening outcomes. The company's products reflect extensive research and development in the fields of gardening and soil science, establishing a strong presence in the growing media market.
C360 Technologies, Inc. specializes in the manufacturing of non-stitched immersive video products tailored for broadcast and over-the-top (OTT) platforms. Established in 2008 and based in Wexford, Pennsylvania, the company has developed innovative technology that allows for high-quality 6K immersive video without the need for multi-headed cameras or stitching. C360's offerings include compact, pro-grade immersive cameras and workstations that provide multiple live HD-SDI outputs directly to broadcasters, facilitating real-time production for live television events. Additionally, the technology enables simultaneous 4K streaming to OTT platforms, allowing for versatile distribution across various applications. Users can independently control camera settings during live events, enhancing the viewing experience. C360 Technologies has positioned itself as a pioneer in the immersive video industry, focusing on delivering unique solutions that meet the demands of modern broadcasting.
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.
Zive, Inc., a consumer software company, develops 'Kiwi for Gmail', an email desktop application for Mac and Windows users. Kiwi for Gmail is up to 2.0, which comes with a new toolbar and allows users to multitask. The application turns G Suite applications like docs and slides, into Windows desktop applications. The company was founded in 2013 and is headquartered in New York, New York.
Anglr is an online platform established in 2016 that connects the global sport fishing community. It offers free mobile applications, patented IoT technologies, and a website designed to enhance the fishing experience. Anglr allows users to track and record details of their fishing adventures, including cast locations, bait used, weather conditions, and catch statistics. This functionality enables fishermen and women to document, analyze, and share their activities, fostering competition and camaraderie among users. By facilitating connections within the fishing community, Anglr transforms fishing into a more social activity, providing additional motivation and engagement even for those fishing alone.
RendrFX is a SaaS-based online plug and play motion graphics messaging maker empowering businesses and individuals to create professional, affordable videos by leveraging video designs curated from its global artist community. Its platform uses online plug and play motion graphics messaging maker by leveraging video designs curated from global artist communities that enable businesses and individuals to create videos with ease and affordability, advertising, and marketing agencies to scale their clients' online video presence and creating a new, fair community for motion graphics artists to sell their work.
Cognition Therapeutics, Inc. is a clinical-stage neuroscience company based in Pittsburgh, Pennsylvania, focused on developing small molecule therapeutics aimed at addressing neurodegenerative and neuro-ophthalmic disorders. Founded in 2007, the company is notable for its drug candidate CT1812, an oral brain-penetrant molecule designed to restore cellular processes disrupted by diseases such as Alzheimer’s and dry age-related macular degeneration. Cognition Therapeutics targets the toxic proteins that contribute to cognitive decline, a key factor in various degenerative diseases of the brain. The company employs proprietary assays and medicinal chemistry to create novel, high-quality drug candidates, addressing an unmet need in the treatment of these complex conditions.
PittMoss LLC manufactures an innovative growing media called PittMoss, which consists of organic additives and recycled paper, catering to commercial greenhouses, nurseries, and home gardeners across the United States. The company also produces PittMoss Prime, a versatile soil amendment that can be combined with compost, existing soil blends, or native soil. Founded in 1994 and based in Ambridge, Pennsylvania, PittMoss focuses on sustainability and environmental responsibility, aiming to enhance soil health and improve gardening outcomes. The company's products reflect extensive research and development in the fields of gardening and soil science, establishing a strong presence in the growing media market.
Rinovum Women's Health, Inc. develops medical devices for women. It offers Stork, a medical device that aids in natural fertility and conception in the privacy of home.
Wombat Security provides information security awareness and training software to help organizations teach their employees to secure behavior. Its Security Education Platform includes integrated knowledge assessments, a library of simulated attacks, and interactive training modules, which have been proven to reduce successful phishing attacks and malware infections by up to 90%.
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
Neuros Medical, Inc. is a neuromodulation company based in Willoughby Hills, Ohio, that specializes in developing proprietary neurostimulation therapies to address unmet medical needs for patients globally. The company’s flagship technology, Electrical Nerve Block, targets the elimination of chronic pain associated with various conditions, including neuroma, residual limb pain, chronic post-surgical pain, and chronic migraines. Additionally, Neuros Medical offers the Neuros Altius System, which features an implantable generator with an integrated rechargeable battery, a cuff electrode, and external devices designed to enhance treatment outcomes. Founded in 2008, the company aims to provide innovative solutions for chronic pain management.
ALung Technologies, Inc. is a medical device company based in Pittsburgh, Pennsylvania, specializing in the development and manufacturing of devices for treating acute respiratory failure. The company's primary product, the Hemolung Respiratory Assist System, serves as a dialysis-like alternative to mechanical ventilation by removing carbon dioxide and delivering oxygen directly into the blood. This technology allows patients' lungs to rest and recover while avoiding the need for intubation and enabling protective ventilation. In addition to the Hemolung system, ALung Technologies also develops the Hattler Catheter, which facilitates extracorporeal gas exchange by circulating blood through a small catheter inserted into the central venous bloodstream. Founded in 1997, the company focuses on innovative solutions for both acute and chronic respiratory disorders.
Physcient, Inc. is a Durham, North Carolina-based company that specializes in the manufacture of surgical instruments, particularly the Differential Dissector, which is designed for blunt dissection. This device is utilized in various surgical fields, including plastic surgery and open general procedures such as thoracic, gastrointestinal, gynecological, urological, peripheral vascular, and orthopedic surgeries. Founded in 2007 by three experienced professionals with extensive backgrounds in life and health sciences technology, Physcient aims to enhance surgical efficiency and promote quicker recovery for patients without altering existing surgical techniques.
Cryothermic Systems (formerly Life Core Technologies) is an American medical device firm that develops a series of products to improve patient outcomes by preventing brain damage. Its product Excel Cryo is a device that lowers the temperature of the brain, which can be applied immediately at the onset of neurologic injury. Cryothermic Systems was founded in 2008 and is based in Cleveland, Ohio.
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
Voci Technologies specializes in developing advanced speech recognition servers that convert audio into text for enterprise applications, aiming to enhance customer insights and monitor performance metrics in call centers. Their flagship product, V-Blaze, caters to businesses of all sizes by providing accurate speech-to-text processing for analysis, as well as a voice-based biometrics solution. The company also offers training, support, and customization services to meet the specific needs of their clients. Voci Technologies serves a variety of industries, particularly those that are highly regulated, by ensuring compliance and safeguarding audio data. Additionally, they produce automatic speech-to-text voicemail outputs for telecommunications companies. Founded in 2008 and based in Pittsburgh, Pennsylvania, Voci Technologies became a subsidiary of Medallia, Inc. in 2020.
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.
Voci Technologies specializes in developing advanced speech recognition servers that convert audio into text for enterprise applications, aiming to enhance customer insights and monitor performance metrics in call centers. Their flagship product, V-Blaze, caters to businesses of all sizes by providing accurate speech-to-text processing for analysis, as well as a voice-based biometrics solution. The company also offers training, support, and customization services to meet the specific needs of their clients. Voci Technologies serves a variety of industries, particularly those that are highly regulated, by ensuring compliance and safeguarding audio data. Additionally, they produce automatic speech-to-text voicemail outputs for telecommunications companies. Founded in 2008 and based in Pittsburgh, Pennsylvania, Voci Technologies became a subsidiary of Medallia, Inc. in 2020.
DiaKine Therapeutics, Inc. is a development stage company commercializing novel immune modulators for the treatment of diabetes and related complications. These drugs have the potential to stop the progression of diabetes and reverse damage already caused by the disease. Therapeutics under development by DiaKine include: adjunct therapy to islet cell transplants (in Phase 2 clinical trial), halting the progression of type 1 diabetes in newly diagnosed adults, treatment and prevention of Latent Autoimmune Diabetes of Adults (LADA), treatment and prevention of insulin requiring type 2 diabetic, treatment and prevention of diabetes complications. DiaKine would like to thank the National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health (NIDDK/NIH) for producing the clinical trials supplies for the trial.
TalkShoe, Inc. operates a Website with user generated live and recorded (podcast) voice and audio content. The company offers TalkShoe, a service that enables users to create, join, and listen to live group calls, conversations, discussions, interactive podcasts, and audio blogs. Its service allows people to use voice and text chat to talk with people with similar interests around the world to discuss various topics, including business, computers, sports, religion, politics, music, arts, science, travel, and more. The company serves talkers and listeners, and bloggers and podcasters. The company was founded in 2005 and is based in Wexford, Pennsylvania. As of May 2, 2016, TalkShoe, Inc. operates as a subsidiary of iotum inc.
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.
The SilentAlert Resident Attendant System is a product of NewCare Solutions, LLC. Located in the Pittsburgh metropolitan area, NewCare Solutions is a spinoff of medSage Technologies, LLC and was created when its founder, William Kaigler, was unable to find an effective and affordable solution to help his 85-year old mother live independently in her home. The SilentAlert Resident Attendant System became a reality after his mother was hospitalized and her sleep was continuously disrupted by an audible bed alarm for another patient.